Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

17.11.2020 back forward

Allergen Product: First European Marketing Authorisation

Peanuts (Source: Ivabalk / Pixabay)

On 17 November 2020, the European Commission authorises the first immunotherapeutic agent for the treatment of allergies in a centralised procedure for the whole of Europe. This means that for the first time a therapeutic agent of proven quality, efficacy and safety is available for the treatment of a food allergy, in this case an allergy to peanuts. The Paul-Ehrlich-Institut, acting as rapporteur, led the authorisation procedure.

First European Marketing Authorisation